HF
RUBY

HRT Financial’s Rubius Therapeutics, Inc RUBY Stock Holding History

HRT Financial’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,425
Closed -$8K – 3552
2022
Q3 		$8K Sell
20,425
-267,527
-93% -$201K ﹤0.01% 2562
2022
Q2 		$244K Buy
287,952
+176,469
+158% +$296K ﹤0.01% 2153
2022
Q1 		$614K Buy
111,483
+89,618
+410% +$569K ﹤0.01% 1488
2021
Q4 		$211K Sell
21,865
-2,959
-12% -$41K ﹤0.01% 2500
2021
Q3 		$443K Buy
+24,824
New +$540K ﹤0.01% 2106
2020
Q4 		– Sell
-46,010
Closed -$230K – 2669
2020
Q3 		$230K Buy
+46,010
New +$244K 0.01% 1282

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's RUBY Position: Q4 2022 in Review

HRT Financial sold out of Rubius Therapeutics, Inc (RUBY) in Q4 2022, closing a stake of 20,425 shares — an estimated $8K sold.

HRT Financial first reported a position in RUBY in Q3 2020 and held it in 6 quarters. The position peaked at $614K in Q1 2022. 42 funds tracked by Wall St. Rank hold RUBY as of Q4 2022.

  • HRT Financial reported no remaining Rubius Therapeutics, Inc position as of Q4 2022 after selling out during the quarter.
  • HRT Financial sold 20,425 Rubius Therapeutics, Inc shares in Q4 2022, an estimated $8K.
  • HRT Financial first reported a position in Rubius Therapeutics, Inc in Q3 2020 and held it in 6 quarters.
  • HRT Financial's Rubius Therapeutics, Inc position peaked at $614K in Q1 2022.
  • 42 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.